Creatine(Cr)-weighted chemical-exchange-saturation-transfer(CEST) MRI is being developed to detect alteration in Cr concentration during modulation as well as Cr-associated disorders. Cr-weighted CEST contrast show dependence on saturation parameters and overlap from other effects in brain. The conventional asymmetry approach results in a mixed contrast, which is less specific to Cr. By using appropriate saturation parameters, contamination from some of the metabolites/molecules can be reduced; however, it is difficult to suppress the contamination completely as shown by simulation studies. Proposed protocol and improved z-spectral fitting approach can be used for computing Cr-weighted CEST contrast with reduced contamination in human brain at 7T.